Colson AE, Crofoot GE, Ruane PJ, Ramgopal MN, et al. Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 : A Phase 2 Randomized Study. Ann Intern Med 2025 Dec 23. doi: 10.7326/ANNALS-25-01939.
PMID: 41429026